<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02197221</url>
  </required_header>
  <id_info>
    <org_study_id>13 7045 01</org_study_id>
    <nct_id>NCT02197221</nct_id>
  </id_info>
  <brief_title>Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With Multiple Myeloma</brief_title>
  <acronym>IFM2014-02</acronym>
  <official_title>IFM 2014-02 Study: A Randomized Phase III Study of Bortezomib-Melphalan 200 Conditioning Regimen Versus Melphalan 200 for Frontline Transplant Eligible Patients With Multiple Myeloma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Janssen, LP</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase III multicenter randomized, open-label study comparing the efficacy of a combined high
      dose chemotherapy using melphalan and bortezomib versus melphalan alone followed by stem cell
      transplant in frontline multiple myeloma patients, non-progressive after induction therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete Response rates (according to IMWG 2011 criteria)</measure>
    <time_frame>60 days post Autologous Stem Cells Transplantation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>overall survival</measure>
    <time_frame>60 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Response rates (according to IMWG 2011 criteria)</measure>
    <time_frame>post ASCT and consolidation therapy</time_frame>
    <description>Compare response rate after ASCT and after the completion of consolidation therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious adverse event</measure>
    <time_frame>End of study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>progression-free survival between the two arms</measure>
    <time_frame>60 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Multiple Myeloma</condition>
  <arm_group>
    <arm_group_label>Bortezomib-Melphalan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bortezomib will be administered on days: -6, -3 +1, +4. Melphalan will be administered on day -2. The PBSC will be injected on day 0.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Melphalan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Melphalan will be administered on day -2. The PBSC will be injected on day 0.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bortezomib-Melphalan</intervention_name>
    <description>Bortezomib will be administered on days: -6, -3, +1, +4. Melphalan will be administered on day -2. The PBSC will be injected on day 0.</description>
    <arm_group_label>Bortezomib-Melphalan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melphalan</intervention_name>
    <description>Melphalan will be administered on day -2. The PBSC will be injected on day 0.</description>
    <arm_group_label>Melphalan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must have results from their initial diagnosis available at the time of screening to
             confirm all the following :

               1. Diagnosis of multiple myeloma according to the diagnostic

               2. Symptomatic de novo Multiple Myeloma

          -  Be eligible for high-dose therapy with autologous stem cell transplantation

          -  Autologous cell graft with a total number of CD 34 cells &gt; or = 5 X 106/kg before
             freezing

        Exclusion Criteria:

          -  Progressive disease

          -  Females participants pregnant or breast-feeding

          -  A known infection by the human immunodeficiency virus

          -  An active viral hepatitis B or C

          -  Unstable angina or myocardial infarction within 4 months prior to inclusion, heart
             failure NYHA class III or IV angina, uncontrolled, history of severe coronary artery
             disease, an uncontrolled serious ventricular arrhythmia, a sick sinus syndrome, or
             electrocardiographic evidence of acute ischemia or conduction disturbances grade 3
             unless the patient has a pacemaker

          -  Uncontrolled hypertension or uncontrolled diabetes within 14 days before enrollment

          -  A history of another malignancy. If cancer was diagnosed more than 10 years and
             considered as cured, an authorization may be requested on a case-by-case basis after
             discussion with the principal investigator

          -  A significant neuropathy of grade 3-4 or grade 2 with pain in the 14 days prior to
             enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel ATTAL, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU TOULOUSE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Murielle ROUSSEL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU TOULOUSE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ROYER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU AMIENS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>DIB, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Angers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>CHAOUI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH ARGENTEUIL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ARAUJO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH BAYONNE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>FONTAN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH BESANCON</affiliation>
  </overall_official>
  <overall_official>
    <last_name>BRECHIGNAC, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HOPITAL AVICENNE BOBIGNY</affiliation>
  </overall_official>
  <overall_official>
    <last_name>MARIT, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU BORDEAUX</affiliation>
  </overall_official>
  <overall_official>
    <last_name>EVEILLARD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU BREST</affiliation>
  </overall_official>
  <overall_official>
    <last_name>MACRO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU CAEN</affiliation>
  </overall_official>
  <overall_official>
    <last_name>MALFUSON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CLAMART PERCY-Hôpital Instruction des Armées</affiliation>
  </overall_official>
  <overall_official>
    <last_name>CHALETEIX, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>HUMBRECHT-KRAUT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Civils de Colmar</affiliation>
  </overall_official>
  <overall_official>
    <last_name>BELHADJ, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Henri Mondor de Creteil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>CAILLOT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU DIJON</affiliation>
  </overall_official>
  <overall_official>
    <last_name>WETTERWALD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH DUNKERQUE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>PEGOURIE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>AGAPE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH LA REUNION-ST DENIS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ZUNIC, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH LA REUNION SAINT PIERRE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>LELEU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU LILLE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>JACCARD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU LIMOGES</affiliation>
  </overall_official>
  <overall_official>
    <last_name>KARLIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>NICOLAS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Léon Bérard de LYON</affiliation>
  </overall_official>
  <overall_official>
    <last_name>STOPPA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Paoli Calmettes Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>DORVAUX, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH METZ</affiliation>
  </overall_official>
  <overall_official>
    <last_name>EISENMANN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH MULHOUSE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>HULIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU NANCY</affiliation>
  </overall_official>
  <overall_official>
    <last_name>MOREAU, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nantes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>LEGROS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU NICE</affiliation>
  </overall_official>
  <overall_official>
    <last_name>BENBRAHIM, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH ORLEANS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>BOUSCARY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Cochin Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>KUHNOWSKI, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Curie Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>MOREL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital la Pitié Salpêtrière Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>GARDERET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Saint Antoine Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ARNULF, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Saint Louis Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>LACOTTE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU POITIERS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>DELMER, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU REIMS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ESCOFFRE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU RENNES</affiliation>
  </overall_official>
  <overall_official>
    <last_name>LENAIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Henri Becquerel de Rouen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>GLAISNER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital René Huguenin - St Cloud</affiliation>
  </overall_official>
  <overall_official>
    <last_name>AUGEL MEUNIER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU ST PRIEST EN JAREZ</affiliation>
  </overall_official>
  <overall_official>
    <last_name>BENBOUBKER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU TOURS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>RIGAUDEAU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CH Versailles</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandrine Rollet</last_name>
    <email>Rollet.Sandrine@iuct-oncopole.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique Universitaire Saint Luc</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>VEKEMANS, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grand Hôpital de Charleroi - Site Notre-Dame</name>
      <address>
        <city>Charleroi</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MINEUR, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Liege</name>
      <address>
        <city>Liege</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CAERS, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Dinant-Godinne UCL Namur</name>
      <address>
        <city>Yvoir</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DOYEN, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH sud Réunion</name>
      <address>
        <city>Saint Pierre</city>
        <state>Ile de La Reunion</state>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ZUNIC, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Felix Guyon</name>
      <address>
        <city>St-denis</city>
        <state>Ile de La Reunion</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AGAPE, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Royer, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DIB, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Argenteuil Victor Dupouy</name>
      <address>
        <city>Argenteuil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CHAOUI, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Bayonne</name>
      <address>
        <city>Bayonne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ARAUJO, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FONTAN, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Avicenne</name>
      <address>
        <city>Bobigny</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BRECHIGNAC, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital du Haut Lévêque</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MARIT, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU DE BREST Hôpital A.Morvan</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>EVEILLARD, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU CAEN</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MACRO, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital d'instruction des armées Percy</name>
      <address>
        <city>Clamart</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MALFUSON, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU d'Estaing</name>
      <address>
        <city>Clermont-ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CHALETEIX, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpitaux civils de Colmar</name>
      <address>
        <city>Colmar</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HUMBRECHT-KRAUT, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BELHADJ, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Dijon - Hôpital des Enfants</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CAILLOT, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Général</name>
      <address>
        <city>Dunkerque</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>WETTERWALD, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PEGOURIE, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU LILLE- Hôpital Claude Huriez</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LELEU, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Limoges</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JACCARD, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon sud</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>KARLIN</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>STOPPA, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de Mercy - CHR Metz Thionville</name>
      <address>
        <city>Metz</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DORVAUX, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Mulhouse</name>
      <address>
        <city>Mulhouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>EISENMANN, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Archet</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CH d'Orléans</name>
      <address>
        <city>Orleans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BENBRAHIM, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MOREL, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-Louis</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ARNULF, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital St-Antoine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GARDERET, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU - Hôpital Jean Bernard</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LACOTTE, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Reims- Hôpital R.Debré</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DELMER, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ESCOFFRE, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LENAIN, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital René Huguenin</name>
      <address>
        <city>St Cloud</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institut de Cancérologie de la Loire Lucien Neuwirth</name>
      <address>
        <city>St-priest-en-jarez</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amandine HUGUET, Pharm D</last_name>
      <phone>5 61 77 84 90</phone>
      <phone_ext>33</phone_ext>
      <email>huguet.a@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Michel ATTAL, MD, Ph D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Murielle ROUSSEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BENBOUBKER, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Nancy</name>
      <address>
        <city>Vandoeuvre</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HULIN, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Versailles-Hôpital André Mignot</name>
      <address>
        <city>Versailles</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>RIGAUDEAU, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2014</study_first_submitted>
  <study_first_submitted_qc>July 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2014</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bortezomib</mesh_term>
    <mesh_term>Melphalan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

